celebrating

20 years

of transforming the workers’ compensation pharmacy and ancillary benefits management experience

Powered by state-of-the-art technology
Supported by human-centered service
Informed by industry expertise
Inspired by a commitment to care

5 Ways We’re Innovating the Digital Experience for Claims Professionals

Claims professionals have long been the frontline of claims management – this has not changed. What has changed is just about everything else.
Read More

The Long Haul: Chronic Health Complications of COVID-19

Those previously infected by coronavirus may face long-term health complications, potentially complicating workers' comp claims
Read More

2021 Industry Insights Survey Report

We surveyed 600+ workers’ comp professionals on the biggest industry disruptors and priorities.
Read More

Personalize my experience

Make selections below to see articles and information related to your role and interests.
  • I am a

  • I'm interested in

FDA Recalls Morphine Sulfate ER Due to Potentially Deadly Label Mix-Up

A mix-up between 30 mg and 60 mg tablets could cause severe adverse events.

Jul 2022

The Cannabis Question: Marijuana and Workplace Safety?

With greater legalization and public approval, the question of safety grows more important.

Jul 2022

Telemedicine Patterns of Use and Reimbursement

A WCRI report explores telemedicine utilization.

Jul 2022

Interstate Variation and Trends in Workers’ Comp Drug Payments

WCRI explores how drug payments varied across 28 states for key drug therapy groups.

Jul 2022

New Drug in Development Could Help Patients with Spinal Cord Injuries

AZD1236, currently in Phase 2 trials, has shown an 80% preservation in nerve function following spinal cord injury.

Jul 2022

No “Set It and Forget It” for Pharmacy Trends, and How Automation Can Lend a Helping Hand

Silvia Sacalis and Tate Rice take turns in WorkCompWire’s Leaders Speak Series.

Jul 2022

Walmart Recalls Supplement for Joint Pain Due to Hidden Drug Ingredients

Artri Ajo King contains undeclared diclofenac, creating safety concerns.

Jun 2022

Out of Stock: Medical Supply Chain Shortages Impacting Worker’s Comp

Ancillary medical product and service shortages and how to manage them.

Jun 2022

Gabapentin-Involved Overdose Deaths on the Rise

A new report from the CDC found that 10% of overdose deaths in 2019-2020 involved gabapentin.

Jun 2022

Rhode Island Legalizes Recreational Marijuana

A total of 19 states now allow for recreational marijuana in adults aged 21 and older.

Jun 2022

Why Novel Physical Therapy Strategies are Getting Attention from Workers’ Comp

Risk and Insurance® magazine speaks to industry professionals, including Healthe’s Director of Product Management, Tate Rice.

Jun 2022

FDA Issues Warning for Consumer Products with Hidden Pain Medications

Undeclared muscle relaxants and anti-inflammatory drugs could interact with a patient’s care.

May 2022

Giving Notice: How Workforce Attrition Impacts Workers’ Comp

Millions of workers are changing occupations, leading to ripple effects for comp.

May 2022

IQVIA Reports on Trends and Future Outlook for Drug Utilization and Spend

Spending and utilization are returning to pre-pandemic levels, with biologics growing in prominence.

May 2022

FDA Considers Requiring Mail-Back Envelopes for Opioid Prescriptions

The public comment period is underway for this action, which could help with safer drug disposal.

May 2022

Silvia Sacalis to Join Panel Presentation at PRIMA 2022

Healthe’s VP of Clinical Services will join a discussion on post-COVID lessons for workers’ comp.

May 2022

Phase 2 Trials for Non-Opioid Pain Medication Deliver Promising Results

VX-548 delivered significant improvements in pain with few adverse events.

Apr 2022

Out of Balance: Workforce Gender Disparities and What They Mean for Workers’ Comp

Women workers were more adversely impacted by the pandemic and the recession.

Apr 2022

Positive Marijuana Drug Screenings Reach All Time High

Quest Diagnostics reports increased positivity rates for marijuana in employee drug screenings.

Apr 2022

FDA Authorizes Second COVID-19 Booster Dose for Special Populations

Adults aged 50 and older and immunocompromised individuals may receive a second booster dose.

Apr 2022

NCCI Reports on Return-to-Work Strategies

Carriers share their thoughts on successful RTW programs.

Apr 2022

Moving Past the Pandemic: Setting a Future Focus

A message from the Chief Executive Officer

Summer 2022

In Harm’s Way: The Impact of Violence in Workers’ Comp

Types of violence that can impact workers’ comp

Summer 2022

The Cannabis Question: Marijuana and Workplace Safety?

With greater legalization and public approval, the question of safety grows more important.

Summer 2022


Out of Stock: Medical Supply Chain Shortages Impacting Workers’ Comp

Ancillary medical product and service shortages and how to manage them.

Summer 2022

Social Influencers: The Role of Social Determinants of Health in Injured Worker Recovery

Gaining visibility into Social Determinants of Health that intersect with workplace injury and recovery

Summer 2022

Giving Notice: How Workforce Attrition Impacts Workers’ Comp

Millions of workers are changing occupations, leading to ripple effects for comp.

Summer 2022

FDA Approves Fleqsuvy for Spasticity

A new muscle relaxant for the treatment of spasticity, including from spinal cord injuries.

Mar 2022

2022 Workers’ Comp Industry Insights Survey Report

Nearly 500 stakeholders share their thoughts on industry challenges and priorities.

Mar 2022

Changing Workforce, Claims Automation and Tech Connectivity Among Top Priorities in 2022 Industry Survey

The priorities and challenges revealed in our 2022 Workers’ Compensation Industry Insights Survey Report reflect an industry focused on moving forward.

Mar 2022

1 2 3 4 5 9 10 11 12 13
lockenvelopephone-handsetmenuarrow-rightcross-circle